Back to List View Graph View

Prodrug

A prodrug is a chemically modified precursor that is converted in the body, or at a selected biological site, into an active therapeutic agent.

Where the papers sit

10 papers from the last 6 months study prodrug directly · updated from PubMed 12 Nov 2026

Study type 0 clinical trials · 1 human data · 8 preclinical · 1 unclassified

Themes 3 themes

  • Programmable Prodrug Delivery

    Prodrug delivery is moving toward spatially and temporally programmed nanoplatforms that coordinate chemotherapy, gene silencing, immunotherapy, and targeted protein degradation. Liposomes, polymeric carriers, and self-assembled floxuridine nanovesicles seek to improve cytotoxicity while limiting off-target exposure. Biointerface switching and neutrophil hitchhiking extend delivery into otherwise resistant tumours. Cereblon-recruiting PROTAC prodrugs broaden the approach beyond conventional cytotoxic drugs.

    4 papers · 40%

  • Stimuli-Responsive Drug Activation

    Selective cleavage is being used to unmask cytotoxic agents in response to light, gold catalysis, or tumour glutathione. Iridium(III) complexes combine photodynamic and photoactivated chemotherapy, while gold-catalysed hydrothiolation enables amide-bond cleavage. Glutathione gradients and temporal dosing improve paclitaxel nanoassembly potency across liver, blood, and tumour compartments. The shared goal is higher cancer-cell efficacy through controlled activation.

    3 papers · 30%

  • Targeted Prodrug Activation

    Biological targeting is being used to activate prodrugs selectively in tumours or defined bacterial species. Engineered probiotics combine local 5-fluorocytosine conversion with immune stimulation, while STING-activating prodrugs aim for durable antitumour immunity and memory. Aminopeptidase activation provides species-selective delivery against Pseudomonas aeruginosa. The common direction is away from systemic exposure and toward context-dependent immune or antimicrobial activity.

    3 papers · 30%

Papers

The 10 papers from the last 6 months that study prodrug directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Programmable Prodrug Delivery (4)
  1. Self-assembled floxuridine prodrug nanovesicles for synergistic drug delivery and gene silencing. Chemical communications (Cambridge, England) · 16 Oct 2026 PMID 42885239
  2. A spatiotemporally programmed neutrophil-hitchhiking polymeric prodrug potentiates cancer immunotherapy. Biomaterials science · 14 Oct 2026 PMID 42872393
  3. Physiologically adaptive prodrug liposomal nanoplatform enables programmable biointerface switching to potentiate cold tumor immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 24 Sept 2026 PMID 42785687
  4. Generalizable Strategies for the Synthesis of Cereblon-Recruiting PROTAC Prodrugs. Angewandte Chemie (International ed. in English) · 5 Aug 2026 PMID 42554619
Stimuli-Responsive Drug Activation (3)
  1. Temporal Dosing Tunes Glutathione Gradient across Liver-Blood-Tumor Axes to Boost the Chemotherapeutic Potency of Prodrug Nanoassemblies. ACS nano · 10 Nov 2026 PMID 43007778
  2. Uncaging Iridium(III) Complexes for Combined Photodynamic and Photoactivated Chemotherapy. Angewandte Chemie (International ed. in English) · 12 Aug 2026 PMID 42585072
  3. Bioorthogonal Gold-Catalyzed Hydrothiolation Leading to Amide Bond Cleavage of Ethynylated Biarylbutanamide Precursors. Journal of the American Chemical Society · 10 Jun 2026 PMID 42267942
Targeted Prodrug Activation (3)
  1. Engineered probiotics for tumor-targeted combination chemoimmunotherapy. Science translational medicine · 16 Sept 2026 PMID 42748218
  2. Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa. ACS infectious diseases · 21 Aug 2026 PMID 42628021
  3. Chemically Regulated STING-Activating Prodrugs of Deoxyribose Cyclic Dinucleotides Elicit Robust Immune Activation and Durable Antitumor Immunity. Angewandte Chemie (International ed. in English) · 21 Jun 2026 PMID 42323807

By study type

Human data, design not indexed (1)
  1. Bioorthogonal Gold-Catalyzed Hydrothiolation Leading to Amide Bond Cleavage of Ethynylated Biarylbutanamide Precursors. Journal of the American Chemical Society · 10 Jun 2026 PMID 42267942
Preclinical: animal, cell and lab studies (8)
  1. Temporal Dosing Tunes Glutathione Gradient across Liver-Blood-Tumor Axes to Boost the Chemotherapeutic Potency of Prodrug Nanoassemblies. ACS nano · 10 Nov 2026 PMID 43007778
  2. Self-assembled floxuridine prodrug nanovesicles for synergistic drug delivery and gene silencing. Chemical communications (Cambridge, England) · 16 Oct 2026 PMID 42885239
  3. A spatiotemporally programmed neutrophil-hitchhiking polymeric prodrug potentiates cancer immunotherapy. Biomaterials science · 14 Oct 2026 PMID 42872393
  4. Physiologically adaptive prodrug liposomal nanoplatform enables programmable biointerface switching to potentiate cold tumor immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 24 Sept 2026 PMID 42785687
  5. Engineered probiotics for tumor-targeted combination chemoimmunotherapy. Science translational medicine · 16 Sept 2026 PMID 42748218
  6. Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa. ACS infectious diseases · 21 Aug 2026 PMID 42628021
  7. Uncaging Iridium(III) Complexes for Combined Photodynamic and Photoactivated Chemotherapy. Angewandte Chemie (International ed. in English) · 12 Aug 2026 PMID 42585072
  8. Chemically Regulated STING-Activating Prodrugs of Deoxyribose Cyclic Dinucleotides Elicit Robust Immune Activation and Durable Antitumor Immunity. Angewandte Chemie (International ed. in English) · 21 Jun 2026 PMID 42323807
Unclassified: not yet indexed with MeSH (1)
  1. Generalizable Strategies for the Synthesis of Cereblon-Recruiting PROTAC Prodrugs. Angewandte Chemie (International ed. in English) · 5 Aug 2026 PMID 42554619